Zhejiang Medicine Co Ltd (600216) - Total Assets
Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) holds total assets worth CN¥14.18 Billion CNY (≈ $2.07 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 600216 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Zhejiang Medicine Co Ltd - Total Assets Trend (1997–2025)
This chart illustrates how Zhejiang Medicine Co Ltd's total assets have evolved over time, based on quarterly financial data. See Zhejiang Medicine Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Zhejiang Medicine Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhejiang Medicine Co Ltd's total assets of CN¥14.18 Billion consist of 51.2% current assets and 48.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 22.5% |
| Accounts Receivable | CN¥1.47 Billion | 10.4% |
| Inventory | CN¥1.85 Billion | 13.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥603.44 Million | 4.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1997–2025)
This chart illustrates how Zhejiang Medicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Zhejiang Medicine Co Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Medicine Co Ltd's current assets represent 51.2% of total assets in 2025, a decrease from 59.5% in 1997.
- Cash Position: Cash and equivalents constituted 22.5% of total assets in 2025, up from 4.1% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is inventory at 13.2% of total assets.
Zhejiang Medicine Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Medicine Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
JW Pharmaceutical Corp
KO:001067
|
Korea | ₩611.56 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Guilin Sanjin Pharmaceutical Co Ltd
SHE:002275
|
China | CN¥4.30 Billion |
|
Fuan Pharmaceutical Group Co
SHE:300194
|
China | CN¥5.97 Billion |
|
DRI Healthcare Trust
TO:DHT-U
|
Canada | $967.26 Million |
|
Hainan Shuangcheng Pharmaceut
SHE:002693
|
China | CN¥816.14 Million |
Zhejiang Medicine Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.39 | 2.85 | 2.16 |
| Quick Ratio | 2.54 | 2.00 | 1.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥5.04 Billion | CN¥4.43 Billion | CN¥3.45 Billion |
Zhejiang Medicine Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Medicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.22 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 2.1% |
| Total Assets | CN¥14.09 Billion |
| Market Capitalization | $1.68 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Medicine Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Medicine Co Ltd's assets grew by 2.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Medicine Co Ltd (1997–2025)
The table below shows the annual total assets of Zhejiang Medicine Co Ltd from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥14.09 Billion ≈ $2.06 Billion |
+2.14% |
| 2024-12-31 | CN¥13.80 Billion ≈ $2.02 Billion |
+7.95% |
| 2023-12-31 | CN¥12.78 Billion ≈ $1.87 Billion |
+2.79% |
| 2022-12-31 | CN¥12.43 Billion ≈ $1.82 Billion |
-0.79% |
| 2021-12-31 | CN¥12.53 Billion ≈ $1.83 Billion |
+19.35% |
| 2020-12-31 | CN¥10.50 Billion ≈ $1.54 Billion |
+1.33% |
| 2019-12-31 | CN¥10.36 Billion ≈ $1.52 Billion |
+3.13% |
| 2018-12-31 | CN¥10.05 Billion ≈ $1.47 Billion |
+2.60% |
| 2017-12-31 | CN¥9.79 Billion ≈ $1.43 Billion |
+11.11% |
| 2016-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
+6.86% |
| 2015-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
+4.82% |
| 2014-12-31 | CN¥7.87 Billion ≈ $1.15 Billion |
+4.14% |
| 2013-12-31 | CN¥7.56 Billion ≈ $1.11 Billion |
+7.07% |
| 2012-12-31 | CN¥7.06 Billion ≈ $1.03 Billion |
+35.75% |
| 2011-12-31 | CN¥5.20 Billion ≈ $760.79 Million |
+12.12% |
| 2010-12-31 | CN¥4.64 Billion ≈ $678.56 Million |
+19.53% |
| 2009-12-31 | CN¥3.88 Billion ≈ $567.71 Million |
+18.86% |
| 2008-12-31 | CN¥3.26 Billion ≈ $477.65 Million |
+14.75% |
| 2007-12-31 | CN¥2.84 Billion ≈ $416.25 Million |
+12.50% |
| 2006-12-31 | CN¥2.53 Billion ≈ $369.98 Million |
+14.52% |
| 2005-12-31 | CN¥2.21 Billion ≈ $323.07 Million |
+20.06% |
| 2004-12-31 | CN¥1.84 Billion ≈ $269.09 Million |
+10.19% |
| 2003-12-31 | CN¥1.67 Billion ≈ $244.20 Million |
+1.96% |
| 2002-12-31 | CN¥1.64 Billion ≈ $239.50 Million |
+4.57% |
| 2001-12-31 | CN¥1.57 Billion ≈ $229.03 Million |
+8.95% |
| 2000-12-31 | CN¥1.44 Billion ≈ $210.22 Million |
-16.49% |
| 1999-12-31 | CN¥1.72 Billion ≈ $251.74 Million |
+52.04% |
| 1998-12-31 | CN¥1.13 Billion ≈ $165.57 Million |
+19.56% |
| 1997-12-31 | CN¥946.35 Million ≈ $138.48 Million |
-- |
About Zhejiang Medicine Co Ltd
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition produ… Read more